Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Formulation and Evaluation of Dispersible Tablets of Lomefloxacin HCl

Veerendra K. Nanjwade, F. V. Manvi, Basavaraj K. Nanjwade

In the present work an attempt has been made to prepare FDT of Lomefloxacin HCl with an view to enhance the patient compliance, and provide a quick onset of action, increasing the solubility and masking its bitter taste. Taste masking and solubility was enhanced by complexing Lomefloxacin HCl with hydroxyl propyl β cyclodextrin (HP-βCD) by solvent evaporation method. Prepared complex was further compressed into tablets by direct compression using different superdisintegrant like Sodium starch glycolate, Croscarmellose sodium, Polyplasdone XL-10 in different concentration such as 1%, 1.5%, 2 % using aspartame as a sweetener and aerosil as lubricant. The drug release from FDT increase with increasing the concentration of superdisintegrants and was found to be highest with formulation F6 containing 1.5 % Croscarmellose Sodium and was consider to be the best formulation which release upto 100.68 % in 45 min. In vivo studies revealed that FDT of formulation (F 6) showed good bioavailability compared to conventional tablet. The fast dissolving tablet with HP-βCD complex can be formulated using different superdisintegrants by Direct Compression technique and was found to be disintegrate less than 2 minute, which provide faster effect and better patient compliance.